临界肢体缺血决策:马尔可夫模拟
研究针对一名63岁合并晚期心衰和糖尿病的临界肢体缺血女性患者,构建马尔可夫决策模型比较截肢、外科旁路、血管内治疗和药物治疗四种策略。基础病例中血管内治疗与外科旁路的贴现质量调整生命月相近(26.50 vs 26.34 QALMs),均优于截肢(18.83)和药物治疗(11.08)。结论对围术期死亡率权重稳健,但对两种血运重建方式的长期死亡率敏感。
要点
- 血管内治疗与外科旁路在临界肢体缺血患者中提供相当的临床结局
- 两种血运重建策略均优于截肢或药物治疗
- 决策对血运重建方式的长期死亡率敏感
核心结论
- 对于临界肢体缺血患者,血管内治疗与外科旁路提供相当的临床结局,但该结论对各自长期死亡率敏感。
- 血管内治疗和外科旁路在一系列情景下均优于截肢或药物治疗。
研究设计与样本
- 研究构建马尔可夫决策模型,评估截肢、外科旁路、血管内治疗和药物治疗4种策略。
- 模型针对一名63岁合并晚期心衰和糖尿病的临界肢体缺血女性患者。
- 采用单因素、双因素和多因素敏感性分析评估参数不确定性的影响。
主要发现
- 基础病例中血管内治疗产生26.50 QALMs,外科旁路为26.34 QALMs。
- 截肢产生18.83 QALMs,药物治疗产生11.08 QALMs。
- 结论对围术期死亡率权重的大范围变化稳健,但对血管内治疗和外科治疗的长期死亡率最敏感。
- 效用权重未按患者合并症分层,但结论对效用权重值范围稳健。
临床怎么用
- 对于合并多种疾病的临界肢体缺血患者,血管内治疗和外科旁路均可作为优于截肢或药物治疗的选择。
- 临床决策需关注不同血运重建方式的长期死亡率差异。
局限性
- 效用权重未按患者合并症进行分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Critical limb ischemia (CLI) is a feared complication of peripheral vascular disease that often requires surgical management and may require amputation of the affected limb. We developed a decision model to inform clinical management for a 63-year-old woman with CLI and multiple medical comorbidities, including advanced heart failure and diabetes. METHODS: We developed a Markov decision model to evaluate 4 strategies: amputation, surgical bypass, endovascular therapy (e.g. stent or revascularization), and medical management. We measured the impact of parameter uncertainty using 1-way, 2-way, and multiway sensitivity analyses. RESULTS: In the base case, endovascular therapy yielded similar discounted quality-adjusted life months (26.50 QALMs) compared with surgical bypass (26.34 QALMs). Both endovascular and surgical therapies were superior to amputation (18.83 QALMs) and medical management (11.08 QALMs). This finding was robust to a wide range of periprocedural mortality weights and was most sensitive to long-term mortality associated with endovascular and surgical therapies. Utility weights were not stratified by patient comorbidities; nonetheless, our conclusion was robust to a range of utility weight values. CONCLUSIONS: For a patient with CLI, endovascular therapy and surgical bypass provided comparable clinical outcomes. However, this finding was sensitive to long-term mortality rates associated with each procedure. Both endovascular and surgical therapies were superior to amputation or medical management in a range of scenarios.
引用
- Deutsch AJ, Jain CC, Blumenthal KG, et al. Decision-Making in Critical Limb Ischemia: A Markov Simulation. Ann Vasc Surg. 2017. PMID: 28739455. doi:10.1016/j.avsg.2017.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。